Drugs / TAK-233
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02113020 | Feb → Sep 2014 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-233 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02113020 ↗ |
| Route | Oral | “Oral administration of TAK-233” NCT02113020 ↗ |